期刊文献+

肺癌住院患者医院感染的病原菌分布及耐药分析 被引量:3

Analysis of Distribution and Drug Resistance of Pathogens of Nosocomial Infections in Patients in Hospital with Lung Cancer
下载PDF
导出
摘要 目的了解肺癌患者医院感染的病原菌分布及耐药性。方法收集2005年6月至2013年6月入住我院的271例肺癌患者的临床资料,进行病原菌分布及耐药性情况分析。结果 271例肺癌患者发生医院感染47例,感染率为17.34%,感染51例次,感染例次率18.82%;以呼吸系统感染为主,占72.54%;病原菌中革兰阴性菌、革兰阳性菌、真菌分别占55.32%、38.30%、6.38%;病原菌对青霉素、头孢曲松、左氧氟沙星等耐药率较高。结论肺癌患者是医院感染的易感人群,医务人员应针对肺癌患者院内感染的病原菌分布及耐药特点进行有效防控。 Objective To explore the distribution and drug resistance of pathogens of nosocomial infections in the lung cancer patients. Methods The clinical information and data of 271 inpatients with lung cancer from Jun 2005 to Jun 2013 were collected, then distribution and drug resistance of pathogens of nosocomial infections were analyzed. Results Totally 271 cases of lung cancer patients, the infections occurred in 47 cases with the infection rate of 17.34%.There were 51 times of case infection, with the rate of case infection times of 18.82%.The main infection site was respiratory system(72.54%).The pathogenic bacteria were gram-negative bacteria(55.32%),gram-positive bacteria(38.30%),and fungus(6.38%).Most of the pathogens were highly resistant to penicillin, ceftriaxone, and levofloxacin. Conclusion The lung cancer inpatients are the susceptible population. Medical staff should pay more attention to the related factors of the nosocomial infections, and take positive and effective measures for preventive control.
出处 《中国医药指南》 2014年第16期79-79,88,共2页 Guide of China Medicine
关键词 肺癌 医院感染 病原菌 耐药性 Lung cancer Nosocomial infection Pathogens Drug resistance
  • 相关文献

参考文献6

二级参考文献30

共引文献6083

同被引文献21

  • 1杨茁,孙莉,任小平.肺癌下呼吸道感染危险因素分析[J].临床肺科杂志,2007,12(6):545-546. 被引量:5
  • 2Eberhardt W,Wilke H,Stamatis G,et al.Preoperative chemotherapy followed by concurrent chemoradiation therapy based on hyperlractionated accelerated radiotherapy and definitive surgery in locally advanced non-small-cell lung cancer:mature results of a phase II trial[J].J Clin Oncol,2008,16(2):622-34.
  • 3Walsh TJ,Lutsar I,Driscoll T,et al.Voriconazole in the treatment of aspergillosis,scedosporiosis and other invasive fungal infections in children[J].Pediatr Infect Dis J,2002,21(3):240-8.
  • 4Crawlord J,Ozer H,Stoller R,et al.Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer[J],N Engl J Med,2011,325(3):164-70.
  • 5Ferlay J.Autier P,Boniol M,et al.Estimates of the cancer incidence and mortality in Europe in 2006[J].Ann Oncol,2007,18(3):581-92.
  • 6Enoch DA,Ludlam HA,Brown NM.Invasive fungal infections:a review of epidemiology and management options[J].J Med Microbiol,2006,55(7):809-18.
  • 7JemaI A,Siegel R,Ward E,et al.Cancer statistics[J],CA Cancer J Clin,2007,57(1):43-66.
  • 8赵建国,熊建萍,项晓军,张凌.晚期肺癌化疗患者医院感染特点与危险因素分析[J].中华医院感染学杂志,2009,19(15):1959-1961. 被引量:29
  • 9赵茹.肺癌328例医院感染分析[J].蚌埠医学院学报,2010,35(3):264-266. 被引量:6
  • 10温建军,曹文静,廖常菊.我院住院患者医院感染现患率调查与分析[J].中国医药导报,2012,9(3):126-127. 被引量:11

引证文献3

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部